196-210 of 813
Strategies and Considerations for Managing MS in Pregnant Women
On the Frontlines of Multiple SclerosisStrategies and Considerations for Managing MS in Pregnant Women
Charles Turck, PharmD, BCPS, BCCCP
Anna A. Shah, MD
Cognitive Impairment in MS: Mitigating Impacts to Optimize Brain Health
NeuroFrontiersCognitive Impairment in MS: Mitigating Impacts to Optimize Brain Health
Christopher Lock, MD
Understanding Prodromal Phases in Demyelinating Diseases: Insights on MS, NMOSD, and MOGAD
NeuroFrontiersUnderstanding Prodromal Phases in Demyelinating Diseases: Insights on MS, NMOSD, and MOGAD
Dalia Rotstein, MD, MPH
Emerging Technologies in MS: Neuromodulation and Myelin Regeneration
NeuroFrontiersEmerging Technologies in MS: Neuromodulation and Myelin Regeneration
Cristin Welle, PhD
MS and Structural Disconnectivity: Pathophysiology and Emerging Technologies
NeuroFrontiersMS and Structural Disconnectivity: Pathophysiology and Emerging Technologies
Amy Kuceyeski, PhD
Multiple Sclerosis Explained: Understanding Its Epidemiology
NeuroFrontiersMultiple Sclerosis Explained: Understanding Its Epidemiology
Jonathan E. Howard, MD
- advertisement
Generalized Myasthenia Gravis Management: Evaluating Long-Term Effects
NeuroFrontiersGeneralized Myasthenia Gravis Management: Evaluating Long-Term Effects
Maxwell H. Levy, MD
Social Support in Schizophrenia: The Role of Emotional Awareness and Regulation
NeuroFrontiersSocial Support in Schizophrenia: The Role of Emotional Awareness and Regulation
David Kimhy, PhD
Uncovering Disparities in Teleneurology Utilization Post-Pandemic
On the Frontlines of Multiple SclerosisUncovering Disparities in Teleneurology Utilization Post-Pandemic
Marisa McGinley, DO
Genetics and Schizophrenia: Key Ethical Considerations
NeuroFrontiersGenetics and Schizophrenia: Key Ethical Considerations
Aaron Besterman, MD
Recognizing Multiple Sclerosis Awareness Month: Ways to Make an Impact
NeuroFrontiersRecognizing Multiple Sclerosis Awareness Month: Ways to Make an Impact
Understanding Schizophrenia: New Insights on Prevalence, Treatment, and Quality of Life
NeuroFrontiersUnderstanding Schizophrenia: New Insights on Prevalence, Treatment, and Quality of Life
Natalie Bareis, PhD, LMSW
- advertisement
Managing MS-Related Fatigue with Therapeutic, Lifestyle, and Behavioral Interventions
On the Frontlines of Multiple SclerosisManaging MS-Related Fatigue with Therapeutic, Lifestyle, and Behavioral Interventions
Glenn Wylie, DPhil
Gaps in Schizophrenia Spectrum Disorders Care: A Look at Causes and Solutions
NeuroFrontiersGaps in Schizophrenia Spectrum Disorders Care: A Look at Causes and Solutions
Natalie Bareis, PhD, LMSW
Fatigue in Multiple Sclerosis: Investigating Longitudinal Determinants
NeuroFrontiersFatigue in Multiple Sclerosis: Investigating Longitudinal Determinants
